BioCentury
ARTICLE | Emerging Company Profile

Neoantigenics: Oocyte oversight

Neoantigenics is targeting oocyte-specific antigens to find, kill cancer cells

August 18, 2014 7:00 AM UTC

Neoantigenics LLC is developing cancer diagnostics and therapeutics based on oocyte-specific proteins that are re-expressed in some cancers. The goal is to create therapies with lower potential to cause side effects, including infertility.

For premenopausal women, many types of cancer treatment, such as chemotherapy, radiotherapy and hormonal treatments, can cause premature menopause or temporary or permanent infertility...